INTRODUCTION
The omentum, like other adipose tissues, contains pre-adipocytes, which share some properties with macrophages. These cells express pattern recognition receptors (PRR) such as Toll-like receptors (TLR) [1] and chemokine receptors [2] and secrete inflammatory mediators including tumor necrosis factor ␣ (TNF-␣) and interleukin-6 [3, 4] . Pre-adipocytes of the omentum are also reported to mature into macrophages, which contribute to local immune and inflammatory responses [5, 6] . Cells within adipose tissue are also now known to have stem cell activity [7] [8] [9] . However, accumulation of macrophages within adipose tissue in obesity and their involvement in inflammation have been highlighted recently [10, 11] . Dendritic antigen-presenting cells (DC; APC) initiate and regulate innate and adaptive immune responses. They can be derived from stem cells shared with macrophages [12] , and monocytes may give rise to DC [13] . We therefore hypothesized that DC, like macrophages, might be obtained from adipose tissue, and to test this hypothesis, we characterized myeloid cells migrating from human omental tissue. We further proposed that DC derived from omentum could contribute to or reflect local inflammatory changes and so, looked for changes in omental DC in the presence of inflammation in Crohn's disease. Hypertrophy of adipose tissue and fat-wrapping characterize Crohn's disease. This adipose tissue shows overexpression of peroxisome proliferator-activated receptor ␥ and increased production of TNF-␣ [14] . Increase in adipose tissue with its inflammatory changes forms the basis for theories that these changes represent a fundamental part of the pathogenic processes producing Crohn's disease. We therefore used omental adipose tissue from these patients to identify whether changes in DC in adipose tissue might contribute to or reflect changes in inflammatory disease.
MATERIALS AND METHODS

Omental samples
Local Ethics Committee permission and informed patient consent were obtained, and omental biopsies were taken from patients undergoing surgery for Crohn's disease (nϭ18, age range 27-62 years, mean 37) with a diagnosis made using clinical parameters, radiographic studies, and histological criteria. Of these patients, eight were not currently receiving treatment, six were on prednisolone with or without nonsteroidal, anti-inflammatory drugs, and the remainder was receiving azathioprine or pentasa. Surgery was indicated from strictures/small bowel obstruction or fistulae. "Controls" were patients undergoing abdominal surgery for benign gynecological conditions including uterine leiomas and cystadenomas (nϭ17, age range 25-69 years, mean 53).
Cells were obtained by a walkout technique developed for enriching DC populations from gut biopsies [15] . Tissue samples were cut into small pieces (1-2 mm 3 ) and put in tissue-culture medium (RPMI 1640, Dutch modification, Sigma, Poole, UK) with 10% fetal calf serum, L-glutamine (2 mM), penicillin (100 IU ml -1 ), and streptomycin (100 g ml -1 ) overnight at 37°C in 5% CO 2 . Tissue was removed on a 100-m sieve, and any red cells were removed by lysis. We originally looked at collagenase-treated cells obtained using a technique for separating "pre-adipocytes". The small number of cells obtained had a phenotype similar to those obtained with the walkout technique. We chose to study only walkout cells more extensively to avoid release of excessive amounts of fat, which cause problems in quantitating and handling cells.
Flow cytometry
Cells were labeled with monoclonal antibodies to cell surface markers directly fluorochrome-conjugated and fixed in 1% paraformaldehyde. Antibodies were fluorescein isothiocyanate (FITC)-conjugated CD45 and CD80, human leukocyte antigen (HLA)-DR, and phycoerythrin-conjugated CD45, CD3, CD19, CD14, CD16, CD34, and CD56 (Becton Dickinson, Oxford, UK); FITCconjugated CD1a, CD40, and CD86 (Serotec, Oxford, UK); FITC-conjugated CD11c (Dako Cytomation, Ely, UK); and FITC-conjugated CD83 (Alexis Biochemicals, Nottingham, UK). Samples were acquired immediately or stored at 4°C and acquired within 36 h. Histogram analysis on the live cell gate used Winlist analysis software (Verity Software House, Topsham, ME). Percentagepositive cells and the intensity ratio, which indicates the ratio of positive-tobackground staining, were determined using the super-enhanced D max subtraction routine in Winlist.
Morphological studies
For electron microscopy between 2 and 10 ϫ 10 5 , freshly isolated, omental cells were processed for electron microscopy. Some cells were surface-labeled with biotinylated anti-major histocompatibility complex (MHC) Class II antibody followed by goat anti-biotin 10 nm gold prior to processing for electron microscopy. At least 100 cells were counted per sample, viewed using a JEOL JEM-1200 EX electron microscope (Osaka, Japan), and assessed for labeling for MHC Class II by counting gold particles per cell. In controls, gold labeling was generally negative and always Ͻ5 gold grains per cell; Ͼ10 grains were considered positive. Macrophages and DC were identified from their characteristic morphology [16] .
Frozen sections were also prepared and stained with CD11c and MHC Class II using the avidin-biotin complex (ABC) method (Vector Laboratories, Peterborough, UK). Slides were air-dried, fixed in cold acetone (-20°C) for 5 min, washed in phosphate-buffered saline (PBS), quenched for 30 min in 3% hydrogen peroxide in methanol, washed in PBS, transferred to a humidified chamber, and incubated for 1 h at room temperature with 5% goat serum in PBS. Slides were incubated with mouse anti-CD11c or HLA-DR primary antibodies (Dako Cytomation) overnight at 5°C, washed and stained with secondary biotinylated antibody for 1 h, stained with ABC for 30 min at room temperature, and developed with peroxidase substrate solution (Vector Laboratories) and were counterstained in hematoxylin, washed, cleared in xylene, and mounted under cover-slips. Control slides were prepared by replacing the primary antibodies with normal serum. Some slides were double-labeled by immunofluorescence microscopy; frozen tissue sections (4 m) were fixed in cold methanol:acetone (1:1) for 10 min, incubated with normal mouse serum for 1 h, washed, and incubated with primary antibody to CD83 (Beckman Coulter, High Wycombe, UK) overnight. Sections washed in PBS were incubated with secondary antibody conjugated with tetramethyl rhodamine isothiocyanate (TRITC) for 2 h and washed again in PBS. To block nonspecific binding sites, sections were incubated with normal mouse serum for 1 h and then incubated with FITC-conjugated primary antibody to CD86, CD80, or CD40 (Serotec) for 4 h, washed in PBS, and mounted under cover-slips using 4Ј,6-diamidino-2-phenylindole-conjugated mounting medium (Vector Laboratories). Negative controls were incubated with appropriate isotype controls.
Mixed leukocyte reactions (MLR)
Large mononuclear cells of low density were enriched from omental cells over a metrizamide gradient (14.5% w/v, Sigma) [17] . These cells were Ͼ85% DC from electron microscopy and phenotyping and were used in varying numbers (500 -2000) with 6.25-100 ϫ 10 3 allogeneic peripheral blood mononuclear cells in triplicate, 20 l hanging drops in Terasaki plates. The stimulatory capacity of these cells was compared with that of DC enriched from mononuclear cells of peripheral blood, and human peripheral blood DC were enriched from the Ficoll-Paque-separated mononuclear cell population by first removing the adherent macrophage population and after 24 h, isolating nonadherent, low-density cells on a metrizamide gradient (14.5%, Sigma) [18] . The cell population contained Ͻ5% B and T cells from labeling with CD20 and CD3. The large mononuclear cells were approximately 30% classical CD14 -DC and 70% CD14 low (intensity of CD14 staining, Ͻ5 times isotype background vs. approximately Ͼ40 times background for freshly isolated monocytes). CD14 -and CD14 low populations have veiled morphology, express costimulatory markers CD80, -86, and -40, and are potent stimulators of primary T cell proliferation; these cells, added at a ratio of less than 1:200 allogeneic T cells, stimulate a MLR. Plates containing cell cultures of DC plus allogeneic T cells were inverted and cultured for 3 days over sterile saline at 37°C and pulsed for 2 h with 3 H thymidine to give a final concentration of 1 g ml -1 (specific activity, 2 Ci/mM, Amersham Biosciences, Amersham, UK). These conditions allow accurate reflection of DNA synthesis in the cells, as they ensure free availability of the alternative pathway precursor throughout the short pulsetime with low levels of radiation-induced damage in cells taking up the thymidine [19] . Cells were then blotted onto filters, washed with saline, trichloroacetic acid (5%), and methanol, and dried. The filter was exposed to a tritium screen for 4 h and imaged in a phosphor imager (Amersham Biosciences). The accumulated counts on the storage phosphor screen were quantitated using ImageQuant software (Molecular Dynamics, Amersham, UK) [17] . This 20-l culture technique produced earlier proliferative responses than those obtained in conventional 200 l cultures. Counts were lower using imaging than those produced from scintillation counting, but the results give Ͼ0.97 correlations between scintillation counts and the counts obtained by imaging [20] . Counts stimulated by concanavalin A, used routinely as a positive control, were 1000 -5000 counts. Significance was tested using twoway ANOVA of log transformed, normally distributed data for each of five omental samples studied in each patient group.
RESULTS
Cells migrating from omental biopsies
Omentum from controls yielded a total of 2.36 Ϯ 0.5 ϫ 10 5 cells per mg tissue, and significantly more cells (11.2Ϯ0.2ϫ10 5 per mg, Pϭ0.001) were from omentum of patients with Crohn's disease (Fig. 1) ; a high proportion of these cells obtained expressed CD45, indicative of a bone marrow origin (Fig. 1 ). There was no significant difference between the proportion of CD45ϩve cells obtained from control and Crohn's omenta (56.6%Ϯ5.1 vs. 40.2%Ϯ8.6). However, by virtue of the increased numbers of cells, over three times as many CD45ϩ cells were obtained from omentum in Crohn's than in controls (4.50Ϯ1.08 vs. 1.33Ϯ0.12ϫ10 5 ). The majority of leukocytes from controls was large mononuclear cells, many with veiled projections. In samples from patients with Crohn's disease, there were, additionally, variable numbers of granulocytes.
Flow cytometry characterization
The light-scatter properties of CD45ϩ cells from control and Crohn's omentum were similar and showed two major cell populations (Fig. 2a, control only shown) . Samples contained few cells positive for T and B cell markers CD3 and CD19, as demonstrated in Figure 2 , b and c, where positive-staining profiles and proportion of those cells positive after subtraction of the isotype control are shown. These putative T and B cells were confined to the smaller cells. Phenotypic markers found within large and small cells were similar, although a lower percentage of the small cells generally expressed DC-associated markers. Expression of CD14 (Fig. 2d) overall was low in comparison with that of monocytes from blood [positive/control intensity ratio of 2.2Ϯ0.4 compared with 56.5Ϯ5.4 (nϭ3)]. In addition, the macrophage marker CD16 (Fig. 2e) and myeloid marker CD33 (data not shown) were expressed on few or no cells. These phenotypic characteristics suggested that conventional monocytes or macrophages were not present; similar results were observed in cells from Crohn's omentum (data not shown). The presence of hematopoietic stem cells was indicated in controls from labeling with CD34 ( Fig. 2f) but was negligible in cells in Crohn's (not shown). There was no evidence of CD56ϩ natural killer cells (Fig. 2g) .
The CD45ϩ cells from controls and Crohn's patients were analyzed for a series of DC-associated markers. Figure 3 shows representative histograms of the labeling for DC-associated markers in CD45ϩve cells from a control and a Crohn's patient. Figure 4 shows the proportion of CD45ϩve cells positive for DC-associated markers from 11 control and nine Crohn's patients. A high proportion of cells expressed the Langerhans cell-associated marker CD1a. Many cells were CD11c-positive (68.4Ϯ6% in controls and 80.9Ϯ3.8 in Crohn's disease), and CD83, a marker appearing during maturation of DC from monocytes, was expressed on high numbers of cells (78.4Ϯ4.6 and 86.7Ϯ3.4% in controls and Crohn's patients, respectively). The costimulatory molecules CD40 and CD86 were expressed (Figs. 3 and 4 
and 78%, 59%, and 73% expressed CD40, CD80, and CD1a, respectively, indicating double-labeling of cells for DC lineage-associated markers and costimulatory marker expression.
Figures 3 and 4 also record differences between phenotypes of cells from control samples and those from Crohn's disease patients. A significantly higher proportion of cells from Crohn's omenta expressed CD11c, suggesting an increase in putative myeloid DC. The costimulatory molecules CD40, CD80, and CD86 were more highly expressed in cells from Crohn's patients, and this elevation was significant for CD40. The intensity of staining for CD40 and CD86 was also greater in cells from Crohn's patients (e.g., Fig. 3 ). In cells from some patients, staining with many antibodies was approximately 90%, even in total cell populations (e.g., for CD11c, CD40, and CD86 in Fig.  3) , and it was again clear that there was multiple labeling of cells using these antibodies. The most striking change was the almost-complete loss of MHC Class II in cells from Crohn's patients, which was not up-regulated even after exposure of the cells to lipopolysaccharide for 2 days in culture. This loss of MHC contrasted with normal levels of MHC Class II on parallel blood samples (nϭ3) of metrizamide gradient-separated blood DC after 24 h of incubation.
Morphological identification of DC
In cytospins of omental walkout cells, we confirmed that there were only occasional lymphocytes and that large mononuclear cells formed the major cell population, some containing obvious lipid droplets; the latter cells appear to be developing adipocytes and may account for the presence of CD45-negative cells within the samples. In control samples, granulocytes were not identified, but in samples from Crohn's patients, granulocytes formed 20 Ϯ 8% of the cells (range 5-45%). As DC are difficult to identify securely using light microscopy, we sought to confirm the presence of DC using electron microscopy. DC enriched using metrizamide gradients were studied in two control samples and two from Crohn's patients. The majority (Ͼ90%) of cells from the controls appeared myeloid cells, of which Ͼ70% were identified as DC (Fig. 5, a and c) ; the remainder was not clearly identifiable or was macrophages (with many round vacuoles of different sizes, heterochromatic nuclei with a rounded or horseshoe shape, and multiple organelles of different types present in a cytoplasm, which often appeared darker than that of the DC). Cells of three morphological types of DC previously identified in DC separated from human peripheral blood were identified in each sample [16] . They included cells with electron dense nuclei, some vacuoles, and numerous short pseudopods as shown in Figure 5 . DC with a smoother cell boundary and fewer processes, resembling Langerhans cells and cells with longer processes, which had a less electron-dense nuclear morphology, similar to that of veiled cells in the afferent lymph, were also present. Over 70% of myeloid cells labeled positively for MHC Class II by immunogold labeling (Fig. 5, b and c) , and many had high levels of gold staining (Fig. 5d) . Amongst mononuclear cells in the samples from Crohn's patients, there was again a high preponderance of veiled cells clearly identified as DC by electron microscopy (65% and 80% in the two studied), and there was no evidence of staining of these cells for MHC Class II, confirming the loss of MHC Class II observed by flow cytometry. The presence in omentum of mononuclear cells of dendritic morphology was also confirmed by immunostaining in light microscopy. Clusters of cells of veiled/dendritic morphology were seen in the omentum in interstices between the adipocytes, and specific staining of these cells for CD11c is shown in Figure 5 , e and f. In the Crohn's disease samples, there was staining for CD11c but not for MHC Class II. In the Crohn's omentum, there were also scattered granulocytes visible (not shown). In frozen sections, double-staining of cells was confirmed using fluorescently labeled antibodies to CD83, which gave the highest level of labeling, and each of the costimulatory molecules (CD40, CD80, and CD86), as exemplified for CD86 in Figure 5 , g and h.
Allogeneic T cell stimulation
The functional hallmark of DC is their potency in stimulating primary, allogeneic T cell proliferation. Large mononuclear cells were separated from omental cells using a metrizamide gradient designed to enrich DC. Small numbers of these separated cells stimulated MLR (Fig. 6) . The counts were similar to or higher than those found in the normal MLR using metrizamide-enriched blood DC as a stimulus (Fig. 6a) . Stimulation was observed when adding putative, allogeneic omental DC at 1-2% of responding mononuclear cells (Fig. 6b) . Cells from all five control omenta stimulated significant, primary MLR (PϭϽ0.001). By contrast, three of five samples from Crohn's patients induced no significant MLR (Fig. 6c) , and the other two stimulated only low levels of proliferation (PϭϽ0.05). The omental cells stimulated higher levels of proliferation than peripheral blood DC, as indicated in the representative experiment shown. In the experiment shown, not only were there lower counts when DC from blood were used, but also, stimulation was still increasing with a dose of stimulator cells, whereas the response had reached a plateau and was lower with the higher dose of omental cells. The higher stimulation could possibly be a result of a greater maturity of the omental DC. The lack of primary T cell stimulation with cells from Crohn's patients was consistent with loss in MHC Class II, identified from flow cytometry and electron microscopy.
DISCUSSION
This paper identifies human adipose tissue, as exemplified by omentum, as a potential, major repository of myeloid DC by showing that significant numbers of these cells migrated from human omental tissue fragments in culture with more than fivefold more DC per mg tissue than are found per ml blood; DC were identified from phenotype, morphology, and immunostaining by light and electron microscopy and function in stimulating, primary, proliferative activity in allogeneic T cells. An increased proportion of putative myeloid (CD11cϩ) DC and higher expression of costimulatory molecules, particularly CD40, with decreased MHC Class II and stimulatory function in cells from omentum in Crohn's patients, bore witness that immunological changes, probably related to inflammation in gut, occurred in cells within omental adipose tissue. An increase in innate activation of DC but loss of ability to stimulate adaptive immunity may be indicated. Cellular as well as biochemical changes within omental adipose tissue may thus be integral to Crohn's disease. The presence of putative DC in adipose tissue, particularly in perinodal adipose tissue, which increases during local stimulation with endotoxin, was suggested in studies of adipose tissue from rats, although no characterization of these cells was undertaken [21] [22] [23] ; mesenteric lymph nodes are embedded in the human omentum. Our identification of DC migrating from human adipose tissue described here and similar cells, which we obtained from mouse omentum [24] , which is close to the spleen, indicates that DC are indeed present in adipose tissue of the omentum.
DC can be obtained as they mature and migrate out of skin or gut tissue fragments [15] . We adapted this method to obtain enriched DC from human omental samples. There were few adipocytes present, as these cells floated and were removed, so avoiding problems of having large quantities of fat present. There was some blood contamination within omental samples, and some cells could possibly derive from this contamination. However, the preponderance of myeloid cells and the presence of higher numbers of DC/mg tissue than there are DC/ml blood ruled out blood as the source of the majority of cells obtained. Occasional omental samples showed pale areas, which may have been "milky spots", but these areas proved impossible to dissect out, as they were fluid rather than structured. The lack of lymphocytes also suggested that we were not obtaining immune cells from structured lymphoid tissue within the fat. All control, omental samples were from females, whereas the Crohn's patients were evenly split between male and female. However, analysis of the numbers of cells from male and female Crohn's patients showed no significant differences in numbers of omental cells. We also saw no evidence that the treatment of some patients was significantly altering the cells that we obtained or their functions.
Expression of MHC Class II is generally considered a defining characteristic of DC and was well represented on a high proportion of the cells from control omentum. The lower MHC Class II found on cells in Crohn's could indicate a loss of DC from omentum in Crohn's. However, the similarity of the phenotype of cells from controls and Crohn's patients argues that these are related to the DC and have lost or lack MHC Class II. The information that control omentum contains stem cells, including hematopoietic stem cells, as indicated from the CD34 labeling, however, could mean that these cells represent cells developing down an alternative maturation pathway. The presence of granulocytes in omentum in Crohn's could indicate that some omental stem cells are maturing down a granulocytic pathway, although recruitment of additional cells from the circulation is an alternative possibility. There is evidence of a close relationship between granulocytes and DC. Thus, granulocytes can be driven to acquire DC characteristics [25] , and an imbalance between granulocytes and DC, favoring production of the former, may contribute to production of autoimmune disease [26] .
The lack of Class II and loss of T cell stimulatory function of cells with the phenotype and morphology of DC in omentum were unexpected. Innate immune mechanisms to bacteria mediated by PRR such as TLR on DC might then underlie the immune activity in the gut [27] . A reduction in the capacity of cells to express MHC and to initiate adaptive immune responses could perhaps represent a mechanism indicating failure of DC to mature and elicit appropriate adaptive immune activity to deal with infecting organisms entering via a gut with an increased permeability. Systemic changes in numbers and functions of DC in Crohn's disease have recently been reported [28] , as well as DC changes in the gut [29] , and it will be of interest in future experiments to examine in more detail DC from these other compartments. The changes in putative DC in Crohn's include an increase in CD40 expression, which has also been observed in DC isolated from the lamina propria of patients with Crohn's, providing a link between the activity of cells in the colon in Crohn's and those in the omentum. The CD40 levels on DC in the colon normalize after treatment with anti-TNF antibody [29] . The elevated production of TNF-␣ in the adipose tissue in Crohn's thus provides a further link between the aberrant activity in the colon and expression of costimulatory markers and the function of DC. The involvement of adipose tissue in the development of Crohn's disease rather than the concept that the changed fat distribution is merely a consequence of the disease process has been postulated [14] . The presence of primary antigen-presenting DC migrating from the omentum suggests that adipose tissue may be a source of local APC. Significant changes in cellular components of adipose tissue in Crohn's disease, taken together with the increased TNF-␣ production in adipose tissue in Crohn's, lend weight to the idea of greater involvement of adipose tissue in disease pathogenesis than has previously been considered, although questions of cause and effect have yet to be elucidated.
Finally, different fatty acids can modulate immune functions differentially, and some evidence suggests that fatty acid distribution is altered in Crohn's disease and that manipulation of dietary fats can be beneficial in its treatment [30] . One possible mechanism of action of fatty acids is via modulation of macrophages, perhaps via effects on TLR [31] . Fatty acids may also block DC function, an effect that is independent of nuclear factor-B activation [32] . Fats are taken up into developing DC, and this uptake is modulated by the effects of cytokine, antigen, or location [24] . The presence of -3 fatty acids particularly can down-regulate immune activity, possibly via the effects of downstream molecules such as prostaglandins [33] . -3 fatty acids fed to rats down-regulate the stimulatory functions of DC [34] , and prostaglandins modulate DC function [35] , suggesting that DC are affected by environmental fatty acids and their downstream products. Perinodal adipose tissue is high in unsaturated fatty acids, which can down-regulate the activity of stimulated lymphocytes [36] . The DC derived from adipose tissue itself may therefore provide a conduit for effects of fatty acids on the immune system. There is loss of -3 fatty acids in the plasma in Crohn's disease [37, 38] and consequent changes in downstream molecules such as prostaglandins with their effects on DC function [35] , providing possible mechanisms via which fatty acids within the adipose tissue may influence APC and produce changes in immune activity in Crohn's disease. We showed that the usual preponderance of unsaturated fatty acids in perinodal adipose tissue was absent in tissue from patients with Crohn's disease with a major loss in -3 fatty acids [39] . However, changes in environmental fatty acids may not be mirrored in lymphoid cells, and the interactions between environmental fatty acids and the cells of the immune system may be critical in determining the metabolic and immune activity [40] . We observed that the fatty acids in lymph node cells from patients with Crohn's disease, unlike those in plasma and adipose tissue, showed a disproportionate loss in -6 fatty acids, leading to a significantly lower-than-normal -6/-3 ratio [39] . Such an increase in the relative proportion of anti-inflammatory -3 fatty acids in immune cells from Crohn's patients may provide a mechanism for the loss in immune activation observed.
In conclusion, these novel studies of DC showing their presence in omental adipose tissue and changes in their number, phenotype, and function in Crohn's disease identify a number of mechanisms by which these omental DC may be involved in local immune responses and altered in inflammatory disease. These data, establishing that DC are present in adipose tissue, also pave the way for evaluation of their source, development pathways, lineage relationships, and a more detailed examination of the way in which adipose tissue DC may be involved in local immune responses in health and in disease.
